CRO Intel

Dashboard Companies Opportunity Signals Clinical Trials Hiring Intelligence Funding Publications FDA Settings

Company Intelligence

Discover companies with clinical, regulatory and hiring signals
Total Companies

6,643

Company Clinical Trials FDA Signals Hiring Opportunity Confidence Last Seen
Shanghai Newislet Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Novamab Biopharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Origincell Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Perhum Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Pharma Biotherapeutics Usa — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Pharmaceutical Group Biological Therapy Technology — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Pharmaceuticals Holding — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Pharmatech — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Qilu Pharmaceutical Research And Development Center — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Rnacure Biopharma — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Roche Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Rona Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Runshi Pharmaceutical Technology — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Rxmidas Pharmaceuticals 1 trials — —
60
36% 		7/17/2026 View Intelligence
Shanghai Sankyo Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Scibrunch Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Shengdi Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Shyndec Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Stem Pharmaceutical Development — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Synergy Pharmaceutical Sciences — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Theorion Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Ultra-t Immune Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Vinnerna Biosciences 1 trials — —
60
36% 		7/17/2026 View Intelligence
Shanghai Vitalgen Biopharma 1 trials — —
60
36% 		7/17/2026 View Intelligence
Shanghai Wanxing Bio-pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Wd Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Weike Biopharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Shanghai World Leader Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Yidian Pharmaceutical Technology Development — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Yingli Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Yinnuo Pharmaceutical Technology — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Yiteng Jingang Bio-pharmaceutical Technology — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Yizhong Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Zhimeng Biopharma — — —
60
36% 		7/17/2026 View Intelligence
Shanghai Zhongze Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Shanton Pharma — — —
60
36% 		7/17/2026 View Intelligence
Shanxi Kangbao Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Shanxi Zhendong Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Shanxi Zhendong Pharmacy — — —
60
36% 		7/17/2026 View Intelligence
Sheffield Pharmaceuticals — — —
60
42% 		7/20/2026 View Intelligence
Sheng Chang Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Sheng Pu Pharmaceutics — — —
60
36% 		7/17/2026 View Intelligence
Shengke Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Shengke Pharmaceuticals (jiangsu) China — — —
60
36% 		7/17/2026 View Intelligence
Shengzhen Sciprogen Bio-pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Shenox Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Shenyang Dongxing Pharmaceutical Technology — — —
60
36% 		7/17/2026 View Intelligence
Shenyang Sunshine Pharmaceutical 1 trials — —
60
36% 		7/17/2026 View Intelligence
Shenzhen Braegen Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Shenzhen Hanchuan e-commerce — — —
60
40% 		7/20/2026 View Intelligence
Showing 5401 - 5450 of 6,643 companies